719
Views
48
CrossRef citations to date
0
Altmetric
Review Article

Chemically induced pheochromocytomas in rats: mechanisms and relevance for human risk assessment

, , , &
Pages 695-718 | Received 10 Apr 2009, Accepted 17 Jul 2009, Published online: 11 Sep 2009

References

  • Arnold DL, Moodie CA, Charbonneau SM, Grice HC, McGuire PF, Bryce FR, Collins BT, Zawidzka ZZ, Krewski DR, Nera EA, et al. (1985). Long-term toxicity of hexachlorobenzene in the rat and the effect of dietary vitamin A. Food Chem Toxicol 23:779–793.
  • Bär A (1986). Sugars and adrenomedullary proliferative lesions: the effects of lactose and various polyalcohols. J Am Coll Toxicol 7:71–81.
  • Bomhard E (1992). Frequency of spontaneous tumors in Wistar rats in 30-months studies. Exp Toxicol Pathol 44:381–392.
  • Bomhard E, Rinke M (1994). Frequency of spontaneous tumours in Wistar rats in 2-year studies. Exp Toxicol Pathol 46:17–29.
  • Bonet ML, Oliver J, Picó C, Felipe F, Ribot J, Cinti S, Palou A (2000). Opposite effects of feeding a vitamin A-deficient diet and retinoic acid treatment on brown adipose tissue uncoupling protein 1 (UCP1), UCP2 and leptin expression. J Endocrinol 166:511–517.
  • Bragadin M, Toninello A, Mancon M, Manente S (2007). The interactions of cobalt(II) with mitochondria from rat liver. J Biol Inorg Chem 12:631–635.
  • Brunelle JK, Bell EL, Quesada NM, Vercauteren K, Tiranti V, Zeviani M, Scarpulla RC, Chandel NS (2005). Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation. Cell Metab 1:409–414.
  • Bucher JR, Hailey JR, Roycroft JR, Haseman JK, Sills RC, Grumbein SL, Mellick PW, Chou BJ (1999). Inhalation toxicity and carcinogenicity studies of cobalt sulfate. Toxicol Sci 49:56–67.
  • Buttigieg J, Brown ST, Lowe M, Zhang M, Nurse CA (2008). Functional mitochondria are required for O2 but not CO2 sensing in immortalized adrenomedullary chromaffin cells. Am J Physiol Cell Physiol 294:C945–C956.
  • Celi FS (2009). Brown adipose tissue—When it pays to be inefficient. New Engl J Med 360:1553–1556.
  • Chan JY, Chan SH, Dai KY, Cheng HL, Chou JL, Chang AY (2006). Cholinergic-receptor-independent dysfunction of mitochondrial respiratory chain enzymes reduced mitochondrial transmembrane potential and ATP depletion underlie necrotic cell death induced by the organophosphate poison mevinphos. Neuropharmacology 51:1109–1119.
  • Chandel NS, McClintock DS, Feliciano CE, Wood TM, Melendez JA, Rodriguez AM, Schumacker PT (2000). Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: A mechanism of O2 sensing. J Biol Chem 275:25130–25138.
  • Chhabra RS, Huff JE, Haseman JK, Elwell MR, Peters AC (1991). Carcinogenicity of p-chloroaniline in rats and mice. Food Chem Toxicol 29:119–124.
  • Costa RM, Yang T, Huynh DP, Pulst SM, Viskochil DH, Silva AJ, Brannan CI (2001). Learning deficits but normal development and tumor predisposition in mice lacking exon 23a of Nf1. Nat Genet 27:399–405.
  • Costa M, Davidson TL, Chen H, Ke Q, Zhang P, Yan Y, Huang C, Kluz T (2005). Nickel carcinogenesis: epigenetics and hypoxia signaling. Mutat Res 592:79–88.
  • Dahia PL, Familial Pheochromocytoma Consortium (2006). Transcription association of VHL and SDH mutations link hypoxia and oxidoreductase signals in pheochromocytomas. Ann N Y Acad Sci 1073:208–220.
  • Davidson T, Chen H, Garrick MD, D’Angelo G, Costa M (2005). Soluble nickel interferes with cellular iron homeostasis. Mol Cell Biochem 279:157–162.
  • De Jonge HR (1973). Toxicity of tetracyclines in rat-small-intestinal epithelium and liver. Biochem Pharmacol 22:2659–2677.
  • DeLellis RA, Dayal Y, Tischler AS, Lee AK, Wolfe HJ (1986). Multiple endocrine neoplasia (MEN) syndromes: Cellular origins and interrelationships. Int Rev Exp Pathol 28:163–215.
  • DeLellis RA, Lloyd RV, Heitz PU, Eng C, eds. (2004). Pathology and genetics of tumours of endocrine organs. In: World Health Organization Classification of Tumours. Lyon, France: IARC Press.
  • Diener RM (1988). Case history. Pheochromocytomas and reserpine: Review of carcinogenicity bioassay. J Am Coll Toxicol 7:95–109.
  • Diener RM, Rac VS, Thompson SW, Spaet RH (1980). Review of the critical findings contained within DHHS publication No NIH 80-1749: Bioassay of reserpine for possible carcinogenicity. Toxicol Pathol 8:1–21.
  • Doi A, Peckham J, Chou B, Dill J, Renne R, Grumbein S, Chhabra R (2004). Development of alpha2u-globulin nephropathy and adrenal medullary pheochromocytomas in male rats following exposure to Stoddard solvent IIC. Inhal Toxicol 16:247–257.
  • Dunnick JK, Hailey JR (1996). Phenolphthalein exposure causes multiple carcinogenic effects in experimental model systems. Cancer Res 56:4922–4926.
  • Duprat P, Snell KC, Hollander CF (1990). Tumours of the Adrenal Gland. IARC Sci Publ No. 99 Lyon, France: IARC, 573–581.
  • Elder EE, Elder G, Larsson C (2005). Pheochromocytoma and functional paraganglioma syndrome: no longer the 10% tumor. J Surg Oncol 89:193–201.
  • English JT, Patel SK, Flanagan MJ (1973). Association of pheochromocytomas with brown fat tumors. Radiology 107:279–281.
  • Evinger MJ, Mathew E, Cikos S, Powers JF, Lee YS, Sheikh S, Ross RA, Tischler AS (2005). Nicotine stimulates expression of the PNMT gene through a novel promoter sequence. J Mol Neurosci 26:39–55.
  • Fowler BA, Kardish RM, Woods JS (1983). Alteration of hepatic microsomal structure and function by indium chloride. Ultrastructural morphometric and biochemical studies. Lab Invest 48:471–478.
  • Gear AR (1974). Rhodamine 6G. A potent inhibitor of mitochondrial oxidative phosphorylation. J Biol Chem 249:3628–3637.
  • Gerald D, Berra E, Frapart YM, Chan DA, Giaccia AJ, Mansuy D, Pouysségur J, Yaniv M, Mechta-Grigoriou F (2004). JunD reduces tumor angiogenesis by protecting cells from oxidative stress. Cell 118:781–794.
  • Ghanayem BI (1989). Metabolic and cellular basis of 2-butoxyethanol-induced hemolytic anemia in rats and assessment of human risk in vitro. Biochem Pharmacol 38:1679–1684.
  • Gimm O (2005). Pheochromocytoma-associated syndromes: Genes proteins and functions of RET, VHL and SDHx. Fam Cancer 4:17–23.
  • Gimm O, Koch CA, Januszewicz A, Opocher G, Neumann HP (2004). The genetic basis of pheochromocytoma. Front Horm Res 31:45–60.
  • Goering PL, Maronpot RR, Fowler BA (1988). Effect of intratracheal gallium arsenide administration on delta-aminolevulinic acid dehydratase in rats: Relationship to urinary excretion of aminolevulinic acid. Toxicol Appl Pharmacol 92:179–193.
  • Goodman DG, Ward JM, Squire RA, Chu KC, Linhart MS (1979). Neoplastic and nonneoplastic lesions in aging F344 rats. Toxicol Appl Pharmacol 48:237–248.
  • Goodman DG, Ward JM, Squire RA, Paxton MB, Reichardt WD, Chu KC, Linhart MS (1980). Neoplastic and nonneoplastic lesions in aging Osborne-Mendel rats. Toxicol Appl Pharmacol 55:433–447.
  • Gottlieb E, Tomlinson IP (2005). Mitochondrial tumour suppressors: A genetic and biochemical update. Nat Rev Cancer 5:857–866.
  • Greim H, ed. (2008). n-Butylzinnverbindungen (article in German). In: Toxikologisch-arbeitsmedizinische Begründungen von MAK-Werten. 44th issue. Weinheim: Wiley-VCH Verlag GmbH, 1–66.
  • Grossman A, Pacak K, Sawka A, Lenders JW, Harlander D, Peaston RT, Reznek R, Sisson J, Eisenhofer G (2006). Biochemical diagnosis and localization of pheochromocytoma: Can we reach a consensus? Ann N Y Acad Sci 1073:332–347.
  • Guzy RD, Schumacker PT (2006). Oxygen sensing by mitochondria at complex III: The paradox of increased reactive oxygen species during hypoxia. Exp Physiol 91:807–819.
  • Haseman JK (1983). Patterns of tumor incidence in two-year cancer bioassay feeding studies in Fischer 344 rats. Fundam Appl Toxicol 3:1–9.
  • Haseman JK, Huff J, Boorman GA (1984). Use of historical control data in carcinogenicity studies in rodents. Toxicol Pathol 12:126–135.
  • Haseman JK, Hailey JR, Morris RW (1998). Spontaneous neoplasm incidences in Fischer 344 rats and B6C3F1 mice in two-year carcinogenicity studies: A National Toxicology Program update. Toxicol Pathol 26:428–441.
  • Haseman JK, Ney E, Nyska A, Rao GN (2003). Effect of diet and animal care/housing protocols on body weight survival tumor incidences and nephropathy severity of F344 rats in chronic studies. Toxicol Pathol 31:674–681.
  • Henschler D, ed. (1990). Pentachlorphenol. In: Toxikologisch-arbeitsmedizinische Begründungen von MAK-Werten. 16th issue. Weinheim: VCH Verlagsgesellschaft mbH (English translation: Henschler D, ed. (1992). Pentachlorophenol. In: Occupational Toxicants. Volume 3. Weinheim: VCH Verlagsgesellschaft mbH, 261–270.)
  • Hervouet E, Cízková A, Demont J, Vojtísková A, Pecina P, Franssen-van Hal NL, Keijer J, Simonnet H, Ivánek R, Kmoch S, Godinot C, Houstek J (2008). HIF and reactive oxygen species regulate oxidative phosphorylation in cancer. Carcinogenesis 29:1528–1537.
  • Higami Y, Yu BP, Shimokawa I, Bertrand H, Hubbard GB, Masoro EJ (1995). Anti-tumor action of dietary restriction is lesion-dependent in male Fischer 344 rats. J Gerontol A Biol Sci Med Sci 50:B72–B77.
  • Howland RD, Alli P (1986). Altered phosphorylation of rat neuronal cytoskeletal proteins in acrylamide induced neuropathy. Brain Res 363:333–339.
  • Huff JE, Eustis SL, Haseman JK (1989). Occurrence and relevance of chemically induced benign neoplasms in long-term carcinogenicity studies. Cancer Metastasis Rev 8:1–21.
  • Huynh TT, Pacak K, Wong DL, Linehan WM, Goldstein DS, Elkahloun AG, Munson PJ, Eisenhofer G (2006). Transcriptional regulation of phenylethanolamine N-methyltransferase in pheochromocytomas from patients with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2. Ann N Y Acad Sci 1073:241–252.
  • Ichihara M, Murakumo Y, Takahashi M (2004). RET and neuroendocrine tumors. Cancer Lett 204:197–211.
  • Iero A, Manente S, Perin G, Bragadin M (2003). Frozen mitochondria as rapid water quality bioassay. Chemosphere 52:1115–1123.
  • Izushi F, Mori T, Ogata M (1988). Effect of phenol and halogenated phenols on energy transfer reactions of liver mitochondria. Acta Med Okayama 42:7–14.
  • Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, Kriegsheim AV, Hebestreit HF, Mukherji M, Schofield CJ, Maxwell PH, Pugh CW, Ratcliffe PJ (2001). Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292:468–472.
  • Johnson GA, Boukma SJ, Platz PA (1970). 2-Mercaptobenzothiazole, an inhibitor of dopamine beta-hydroxylase. J Pharm Pharmacol 22:710–712.
  • Johnson KA, Gorzinski SJ, Bodner KM, Campbell RA, Wolf CH, Friedman MA, Mast RW (1986). Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol 85:154–168.
  • Karagiannis A, Mikhailidis DP, Athyros VG, Harsoulis F (2007). Pheochromocytoma: An update on genetics and management. Endocr Relat Cancer 14:935–956.
  • Kim WY, Kaelin WG (2004). Role of VHL gene mutation in human cancer. J Clin Oncol 22:4991–5004.
  • Kishimoto T, Yamaguchi K, Nagake Y, Miki S, Ono T (1990). [A case of asbestos exposure complicated by a malignant pheochromocytoma] (Article in Japanese) Gan No Rinsho 36:2163–2166.
  • Klimova T, Chandel NS (2008). Mitochondrial complex III regulates hypoxic activation of HIF. Cell Death Differ 15:660–666.
  • Koukourakis MI, Giatromanolaki A, Sivridis E, Gatter KC, Harris AL; Tumor and Angiogenesis Research Group (2005). Pyruvate dehydrogenase and pyruvate dehydrogenase kinase expression in non small cell lung cancer and tumor-associated stroma. Neoplasia 7:1–6.
  • Kurokawa Y, Hayashi Y, Maekawa A, Takahashi M, Kukubo T (1985). High incidences of pheochromocytomas after long-term administration of retinol acetate to F344/DuCrj rats. J Natl Cancer Inst 74:715–723.
  • Kytölä S, Nord B, Elder EE, Carling T, Kjellman M, Cedermark B, Juhlin C, Höög A, Isola J, Larsson C (2002). Alterations of the SDHD gene locus in midgut carcinoids, Merkel cell carcinomas, pheochromocytomas, and abdominal paragangliomas. Genes Chromosomes Cancer 34:325–332.
  • Lean ME, James WP, Jennings G, Trayhurn P (1986). Brown adipose tissue in patients with phaeochromocytoma. Int J Obes 10:219–227.
  • Le Hir H, Colucci-D’Amato LG, Charlet-Berguerand N, Plouin PF, Bertagna X, de Franciscis V, Thermes C (2000). High levels of tyrosine phosphorylated proto-ret in sporadic pheochromocytomas. Cancer Res 60:1365–1370.
  • Lim DY, Park HG, Miwa S (2006). CCCP enhances catecholamine release from the perfused rat adrenal medulla. Auton Neurosci 128:37–47.
  • López-Barneo J, Ortega-Sáenz P, Pardal R, Pascual A, Piruat JI (2008). Carotid body oxygen sensing. Eur Respir J 32:1386–1398.
  • Lynch BS, Tischler AS, Capen CC, Munro IC, McGirr LM, McClain RM (1996). Low digestible carbohydrates (polyols and lactose): Significance of adrenal medullary proliferative lesions in the rat. Reg Toxicol Pharmacol 23:256–297.
  • MacKenzie ED, Selak MA, Tennant DA, Payne LJ, Crosby S, Frederiksen CM, Watson DG, Gottlieb E (2007). Cell-permeating alpha-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells. Mol Cell Biol 27:3282–3289.
  • Manger WM (2006). An overview of pheochromocytoma. History, current concepts, vagaries, and diagnostic challenges. Ann N Y Acad Sci 1073:1–20.
  • Marignol L, Lawler M, Coffey M, Hollywood D (2005). Achieving hypoxia-inducible gene expression in tumors. Cancer Biol Ther 4:359–364.
  • Marx SJ (2005). Molecular genetics of multiple endocrine neoplasia types 1 and 2. Nat Rev Cancer 5:367–375.
  • Maynard MA, Ohh M (2004). Von Hippel-Lindau tumor suppressor protein and hypoxia-inducible factor in kidney cancer. Am J Nephrol 24:1–13.
  • McMartin DN, Sahota PS, Gunson DE, Hsu HH, Spaet RH (1992). Neoplasms and related proliferative lesions in control Sprague-Dawley rats from carcinogenicity studies. Historical data and diagnostic considerations. Toxicol Pathol 20:212–225.
  • Metzger RR, Brown JM, Sandoval V, Rau KS, Elwan MA, Miller GW, Hanson GR, Fleckenstein AE (2002). Inhibitory effect of reserpine on dopamine transporter function. Eur J Pharmacol 456:39–43.
  • Mickiewicz W, Rzeczycki W (1988). Effect of styrene and other alkyl benzene derivatives on oxidation of FAD- and NAD-linked substrates in rat liver mitochondria. Biochem Pharmacol 37:4439–4444.
  • Mohr U, ed. (2001). International Classification of Rodent Tumors: The Mouse. Berlin, Heidelberg: Springer, 300–322.
  • Mohr U, Althoff J, Kinzel V (1969). Geschwülste des Nebennierenmarkes bei der Ratte (article in German). Exp Pathol 3:153–158.
  • Mugford CA, Carfagna MA, Kedderis GL (1997). Furan-mediated uncoupling of hepatic oxidative phosphorylation in Fischer-344 rats—An early event in cell death. Toxicol Appl Pharmacol 144:1–11.
  • Nanmoku T, Takekoshi K, Fukuda T, Ishii K, Isobe K, Kawakami Y (2005). Stimulation of catecholamine biosynthesis via the PKC pathway by prolactin-releasing peptide in PC12 rat pheochromocytoma cells. J Endocrinol 186:233–239.
  • Neumann HP, Hoegerle S, Manz T, Brenner K, Iliopoulos O (2002). How many pathways to pheochromocytoma? Semin Nephrol 22:89–99.
  • NTP (National Toxicology Program) (1978a). Bioassay of 1,1,2-trichloroethane for possible carcinogenicity (CAS No 79-00-5). Technical Report Series No 74. Bethesda, MD: National Institutes of Health.
  • NTP (National Toxicology Program) (1978b). Bioassay of 4-chloro-m-phenylenediamine for possible carcinogenicity (CAS No 5131-60-2). Technical Report Series No 85. Bethesda, MD: National Institutes of Health.
  • NTP (National Toxicology Program) (1978c). Bioassay of aniline hydrochloride for possible carcinogenicity (CAS No 142-04-1). Technical Report Series No 130. Bethesda, MD: National Institutes of Health.
  • NTP (National Toxicology Program) (1979a). Bioassay of 5-chloro-o-toluidine for possible carcinogenicity (CAS No 95-79-4). Technical Report Series No 187. Bethesda, MD: National Institutes of Health.
  • NTP (National Toxicology Program) (1979b). Bioassay of p-chloroaniline for possible carcinogenicity (CAS No 106-47-8). Technical Report Series No 189. Bethesda, MD: National Institutes of Health.
  • NTP (National Toxicology Program) (1979c). Bioassay of malathion for possible carcinogenicity (CAS No 121-75-5). Technical Report Series No 192. Bethesda, MD: National Institutes of Health.
  • NTP (National Toxicology Program) (1980). Bioassay of phenol for possible carcinogenicity (CAS No108-95-2). Technical Report Series No 203. Bethesda, MD: National Institutes of Health.
  • NTP (National Toxicology Program) (1982a). Bioassay of reserpine for possible carcinogenicity (CAS No 50-55-5). Technical Report Series No 193. Bethesda, MD: National Institutes of Health.
  • NTP (National Toxicology Program) (1982b). Carcinogenesis bioassay of propyl gallate (CAS No 121-79-9) in F344/N rats and B6C3F1 mice (feed study). Technical Report Series No 240. Bethesda, MD: National Institutes of Health.
  • NTP (National Toxicology Program) (1983). Carcinogenesis studies of 4,4’-methylenedianiline dihydrochloride (CAS No 13552-44-8) in F344/N rats and B6C3F1 mice (drinking water studies). Technical Report Series No 248. Bethesda, MD: National Institutes of Health.
  • NTP (National Toxicology Program) (1984). Toxicology and carcinogenesis studies of tris(2-ethylhexyl)phosphate (CAS No 78-42-2) in F344/N rats and B6C3F1 mice (gavage studies). Technical Report Series No 274. Bethesda, MD: National Institutes of Health.
  • NTP (National Toxicology Program) (1985). Toxicology and carcinogenesis studies of 12-dichlorobenzene (o-dichlorobenzene) (CAS No 95-50-1) in F344/N rats and B6C3F1 mice (gavage studies). Technical Report Series No 255. Bethesda, MD: National Institutes of Health.
  • NTP (National Toxicology Program) (1986a). Toxicology and carcinogenesis studies of CI Basic Red 9 monohydrochloride (pararosaniline) (CAS No 569-61-9) in F344/N rats and B6C3F1 mice (feed studies). Technical Report Series No 285. Bethesda, MD: National Institutes of Health.
  • NTP (National Toxicology Program) (1986b). Toxicology and carcinogenesis studies of benzene (CAS No 71-43-2) in F344/N rats and B6C3F1 mice (gavage studies). Technical Report Series No 289. Bethesda, MD: National Institutes of Health.
  • NTP (National Toxicology Program) (1986c). Toxicology and carcinogenesis studies of chlorinated paraffins (C23 43% chlorine) (CAS No 108171-27-3) in F344/N rats and B6C3F1 mice (gavage studies). Technical Report Series No 305. Bethesda, MD: National Institutes of Health.
  • NTP (National Toxicology Program) (1987a). Toxicology and carcinogenesis studies of oxytetracycline hydrochloride (CAS No 2058-46-0) in F344/N rats and B6C3F1 mice (feed studies). Technical Report Series No 315. Bethesda, MD: National Institutes of Health.
  • NTP (National Toxicology Program) (1987b). Toxicology and carcinogenesis studies of ampicillin trihydrate (CAS No 7177-48-2) in F344/N rats and B6C3F1 mice (gavage studies). Technical Report Series No 318. Bethesda, MD: National Institutes of Health.
  • NTP (National Toxicology Program) (1987c). Toxicology and carcinogenesis studies of 1,4-dichlorobenzene (CAS No 106-46-7) in F344/N rats and B6C3F1 mice (gavage studies). Technical Report Series No 319. Bethesda, MD: National Institutes of Health.
  • NTP (National Toxicology Program) (1988a). Toxicology and carcinogenesis studies of 4-hexylresorcinol (CAS No 136-77-6) in F344/N rats and B6C3F1 mice (gavage studies). Technical Report Series No 330. Bethesda, MD: National Institutes of Health.
  • NTP (National Toxicology Program) (1988b). Toxicology and carcinogenesis studies of 2-mercaptobenzothiazole (CAS No 149-30-4) in F344/N rats and B6C3F1 mice (gavage studies). Technical Report Series No 332. Bethesda, MD: National Institutes of Health.
  • NTP (National Toxicology Program) (1989a). Toxicology and carcinogenesis studies of two pentachlorophenol technical-grade mixtures (CAS No 87-86-5) in B6C3F1 mice (feed studies). Technical Report Series No 349. Bethesda, MD: National Institutes of Health.
  • NTP (National Toxicology Program) (1989b). Toxicology and carcinogenesis studies of para-chloroaniline hydrochloride (CAS No 20265-96-7) in F344/N rats and B6C3F1 mice (gavage studies). Technical Report Series No 351. Bethesda, MD: National Institutes of Health.
  • NTP (National Toxicology Program) (1989c). Toxicology and carcinogenesis studies of hexachloroethane (CAS No 67-72-1) in F344/N rats (gavage studies). Technical Report Series No 361. Bethesda, MD: National Institutes of Health.
  • NTP (National Toxicology Program) (1989d). Toxicology and carcinogenesis studies of bromoethane (ethyl bromide) (CAS No 74-96-4) in F344/N rats and B6C3F1 mice (inhalation studies). Technical Report Series No 363. Bethesda, MD: National Institutes of Health.
  • NTP (National Toxicology Program) (1989e). Toxicology and carcinogenesis studies of rhodamine 6G (CI Basic Red 1) (CAS No 989-38-8) in F344/N rats and B6C3F1 mice (feed studies). Technical Report Series No 364. Bethesda, MD: National Institutes of Health.
  • NTP (National Toxicology Program) (1990a). Toxicology and carcinogenesis studies of mirex (1,1a,2,2,3,3a,4,5,5,5a,5b,6-dodecachlorooctahydro-134-metheno-1H-cyclouta[cd]pentalene) (CAS No 2385-85-5) in F344/N rats (feed studies). Technical Report Series No 313. Bethesda, MD: National Institutes of Health.
  • NTP (National Toxicology Program) (1990b). Toxicology and carcinogenesis studies of phenylbutazone (CAS No 50-33-9) in F344/N rats and B6C3F1 mice (gavage studies). Technical Report Series No 367. Bethesda, MD: National Institutes of Health.
  • NTP (National Toxicology Program) (1991). Toxicology and carcinogenesis studies of CI Acid Red 114 (CAS No 6459-94-5) in F344/N rats (drinking water studies). Technical Report Series No 405. Bethesda, MD: National Institutes of Health.
  • NTP (National Toxicology Program) (1992a). Toxicology and carcinogenesis studies of γ-butyrolactone (CAS No 96-48-0) in F344/N rats and B6C3F1 mice (gavage studies). Technical Report Series No 406. Bethesda, MD: National Institutes of Health.
  • NTP (National Toxicology Program) (1992b). Toxicology and carcinogenesis studies of CI Pigment Red 3 (CAS No 2425-85-6) in F344/N rats and B6C3F1 mice (feed studies). Technical Report Series No 407. Bethesda, MD: National Institutes of Health.
  • NTP (National Toxicology Program) (1992c). Toxicology and carcinogenesis studies of polysorbate 80 (CAS No 9005-65-6) in F344/N rats and B6C3F1 mice (feed studies). Technical Report Series No 415. Bethesda, MD: National Institutes of Health.
  • NTP (National Toxicology Program) (1993a). Toxicology and carcinogenesis studies of furan (CAS No 110-00-9) in F344 rats and B6C3F1 mice (gavage studies). Technical Report Series No 402. Bethesda, MD: National Institutes of Health.
  • NTP (National Toxicology Program) (1993b). Toxicology and carcinogenesis studies of pentachloroanisole (CAS No 1825-21-4) in F344 rats and B6C3F1 mice (feed studies). Technical Report Series No 414. Bethesda, MD: National Institutes of Health.
  • NTP (National Toxicology Program) (1993c). Toxicology and carcinogenesis studies of talc (CAS No 14807-96-6) (non-asbestiform) in F344/N rats and B6C3F1 mice (inhalation studies). Technical Report Series No 421. Bethesda, MD: National Institutes of Health.
  • NTP (National Toxicology Program) (1996a). Toxicology and carcinogenesis studies of nickel oxide (CAS No 1313-99-1) in F344 rats and B6C3F1 mice (inhalation studies). Technical Report Series No 451. Bethesda, MD: National Institutes of Health.
  • NTP (National Toxicology Program) (1996b). Toxicology and carcinogenesis studies of nickel subsulfide (CAS No 12035-72-2) in F344 rats and B6C3F1 mice (inhalation studies). Technical Report Series No 453. Bethesda, MD: National Institutes of Health.
  • NTP (National Toxicology Program) (1996c). Toxicology and carcinogenesis studies of phenolphthalein (CAS No 77-09-8) in F344 rats and B6C3F1 mice (feed studies). Technical Report Series No 465. Bethesda, MD: National Institutes of Health.
  • NTP (National Toxicology Program) (1998). Toxicology and carcinogenesis studies of cobalt sulfate heptahydrate (CAS No 10026-24-1) in F344/N rats and B6C3F1 mice (inhalation studies). Technical Report Series No 471. Bethesda, MD: National Institutes of Health.
  • NTP (National Toxicology Program) (1999). Toxicology and carcinogenesis studies of oxymetholone (CAS No 434-07-1) in F344/N rats and toxicology studies of oxymetholone in B6C3F1 mice (gavage studies). Technical Report Series No 485. Bethesda, MD: National Institutes of Health.
  • NTP (National Toxicology Program) (2000a). Toxicology and carcinogenesis studies of 2-butoxyethanol (CAS No 111-76-2) in F344/N rats and B6C3F1 mice (inhalation studies). Technical Report Series No 484. Bethesda, MD: National Institutes of Health.
  • NTP (National Toxicology Program) (2000b). Toxicology and carcinogenesis studies of gallium arsenide (CAS No 1303-00-0) in F344/N rats and B6C3F1 mice (inhalation studies). Technical Report Series No 492. Bethesda, MD: National Institutes of Health.D
  • NTP (National Toxicology Program) (2001). Toxicology and carcinogenesis studies of indium phosphide (CAS No 22398-80-7) in F344/N rats and B6C3F1 mice (inhalation studies). Technical Report Series No 499. Bethesda, MD: National Institutes of Health.
  • NTP (National Toxicology Program) (2004). Toxicology and carcinogenesis studies of Stoddard Solvent IIC (CAS No 64742-88-7) in F344/N rats and B6C3F1 mice (inhalation studies). Technical Report Series No 519. Bethesda, MD: National Institutes of Health.
  • NTP (National Toxicology Program) (2005). Toxicology and carcinogenesis studies of decalin (CAS No 91-17-8) in F344/N rats and B6C3F1 mice and a toxicology study of decalin in male NBR rats (inhalation studies). Technical Report Series No 513. Bethesda, MD: National Institutes of Health.
  • Nyska A, Haseman JK, Hailey JR, Smetana S, Maronpot RR (1999). The association between severe nephropathy and pheochromocytoma in the male F344 rat—The National Toxicology Program experience. Toxicol Pathol 27:456–462.
  • Ozaki K, Haseman JK, Hailey JR, Marenpot RR, Nyska A (2002). Association of adrenal pheochromocytoma and lung pathology in inhalation studies with particulate compounds in the male F344 rat—The National Toxicology Program experience. Toxicol Pathol 30:263–270.
  • Palou A, Picó C, Bonet ML, Oliver P (1998). The uncoupling protein thermogenin. Int J Biochem Cell Biol 30:7–11.
  • Patel SP, Sullivan PG, Pandya JD, Rabchevsky AG (2008). Differential effects of the mitochondrial uncoupling agent 24-dinitrophenol or the nitroxide antioxidant Tempol on synaptic or nonsynaptic mitochondria after spinal cord injury. J Neurosci Res 87:130–140.
  • Perlman RL, Sheard BE (1982). Estimation of the cytoplasmic catecholamine concentrations in pheochromocytoma cells. Biochim Biophys Acta 719:334–340.
  • Pelgrom SMGJ, van Raaij MTM (2000). Pheochromocytomas. Factsheet FSV-003/00. In: Factsheets for the (Eco)Toxicological Risk Assessment Strategy of the National Institute of Public Health and the Environment (RIVM). Report 601516007. Luttik R, van Raaij MTM, eds., 39–47.
  • Piruat JI, Pintado CO, Ortega-Sáenz P, Roche M, López-Barneo J (2004). The mitochondrial SDHD gene is required for early embryogenesis and its partial deficiency results in persistent carotid body glomus cell activation with full responsiveness to hypoxia. Mol Cell Biol 24:10933–10940.
  • Pollard M, Luckert PH (1989). Spontaneous diseases in aging Lobund-Wistar rats. Prog Clin Biol Res 287:51–60.
  • Pollard PJ, Wortham NC, Tomlinson IP (2003). The TCA cycle and tumorigenesis: the examples of fumarate hydratase and succinate dehydrogenase. Ann Med 35:632–639.
  • Pollard PJ, Brière JJ, Alam NA, Barwell J, Barclay E, Wortham NC, Hunt T, Mitchell M, Olpin S, Moat SJ, Hargreaves IP, Heales SJ, Chung YL, Griffiths JR, Dalgleish A, McGrath JA, Gleeson MJ, Hodgson SV, Poulsom R, Rustin P, Tomlinson IP (2005). Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. Hum Mol Genet 14:2231–2239.
  • Pollard PJ, El-Bahrawy M, Poulsom R, Elia G, Killick P, Kelly G, Hunt T, Jeffery R, Seedhar P, Barwell J, Latif F, Gleeson MJ, Hodgson SV, Stamp GW, Tomlinson IP, Maher E (2006). Expression of HIF-1alpha, HIF-2alpha (EPAS1) and their target genes in paraganglioma and pheochromocytoma with VHL and SDH mutations. J Clin Endocrinol Metab 91:4593–4598.
  • Powers JF, Brachold JM, Ehsani SA, Tischler AS (2005). Up-regulation of ret by reserpine in the adult rat adrenal medulla. Neuroscience 132:605–612 [Erratum in: Neuroscience (2006). 137:365–366.]
  • Powers JF, Picard KL, Nyska A, Tischler AS (2008). Adrenergic differentiation and Ret expression in rat pheochromocytomas. Endocr Pathol 19:9–16.
  • Puigserver P, Vázquez F, Bonet ML, Picó C, Palou A (1996). In vitro and in vivo induction of brown adipocyte uncoupling protein (thermogenin) by retinoic acid. Biochem J 317:827–833.
  • Quevedo L, Montoya G, Ferraris R, Venegas W (1992). Inhibition of the sodium transport by pentachlorophenol (PCP) in toad skin (Pleurodema thaul). Comp Biochem Physiol C 101:365–369.
  • Rankin EB, Giaccia AJ (2008). The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ 15:678–685.
  • Ratcliffe PJ (2006). Understanding hypoxia signalling in cells—A new therapeutic opportunity? Clin Med 6:573–578.
  • Ritzl F (1972). [Effect of phenylbutazone on oxidative phosphorylation] (article in German). Arzneimittelforschung 22:912–914.
  • Rosol TJ, Yarrington JT, Latendresse J, Capen CC (2001). Adrenal gland: Structure, function, and mechanisms of toxicity. Toxicol Pathol 29:41–48.
  • Sabri MI (1994). Attenuation of glyceraldehyde-3-phosphate dehydrogenase activity and ATP levels in rat brain synaptosomes by acrylamide. Neurochem Res 19:1439–1444.
  • Salnikow K, Donald SP, Bruick RK, Zhitkovich A, Phang JM, Kasprzak KS (2004). Depletion of intracellular ascorbate by the carcinogenic metals nickel and cobalt results in the induction of hypoxic stress. J Biol Chem 279:40337–40344.
  • Santa Cruz V, Dugas TR, Kanz MF (2005). Mitochondrial dysfunction occurs before transport or tight junction deficits in biliary epithelial cells exposed to bile from methylenedianiline-treated rats. Toxicol Sci 84:129–138.
  • Schardein JL, Fitzgerald JE, Kaump DH (1968). Spontaneous tumors in Holtzman-source rats of various ages. Pathol Vet 5:238–252.
  • Selak MA, Armour SM, MacKenzie ED, Boulahbel H, Watson DG, Mansfield KD, Pan Y, Simon MC, Thompson CB, Gottlieb E (2005). Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 7:77–85.
  • Semenova LP, Nikol’skaia TA, Emanuel’ NM (1965). [Oxidation phosphorylation and respiration in liver mitochondria and solid hepatoma of mice suppressed by propylgallate] (article in Russian). Dokl Akad Nauk SSSR 163:774–776.
  • Semenza GL (2003). Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3:721–732.
  • Shannon RD, Boardman GD, Dietrich AM, Bevan DR (1991). Mitochondrial response to chlorophenols as a short-term toxicity assay. Environ Toxicol Chem 10:57–66.
  • Sher SP, Jensen RD, Bokelman DL (1982). Spontaneous tumors in control F344 and Charles River-CD rats and Charles River CD-1 and B6C3HF1 mice. Toxicol Lett 11:103–110.
  • Solleveld HA, Haseman JK, McConnell EE (1984). Natural history of body weight gain survival and neoplasia in the F344 rat. J Natl Cancer Inst 72:929–940.
  • Spicer Z, Millhorn DE (2003). Oxygen sensing in neuroendocrine cells and other cell types: Pheochromocytoma (PC12) cells as an experimental model. Endocr Pathol 14:277–291.
  • Strandberg JD (1983). Hyperplasia and neoplasia. In: Jones TC, Mohr U, Hunt RD, Capen CC, eds. Endocrine System. Springer Berlin, Heidelberg: Springer, 18–27.
  • Tanizawa H, Terada M, Watanabe Y (1976). [Experimental studies on anthelmintics (XXVI). Biochemical and pharmacological studies of 4-iodothymol on Ascaris lumbricoides suum] (article in Japanese). Nippon Yakurigaku Zasshi 72:493–499.
  • Taylor SC, Shaw SM, Peers C (2000). Mitochondrial inhibitors evoke catecholamine release from pheochromocytoma cells. Biochem Biophys Res Commun 273:17–21.
  • Terada H (1990). Uncouplers of oxidative phosphorylation. Environ Health Perspect 87:213–218.
  • Tischler AS (1996). Cell proliferation in the adult adrenal medulla: Chromaffin cells as a model for indirect carcinogenesis. In: Jones TC, Capen CC, Mohr U, eds. ILSI Monographs on Pathology of Laboratory Animals Endocrine System. Berlin: Springer, 405–411.
  • Tischler AS (2000). Divergent differentiation in neuroendocrine tumors of the adrenal gland. Semin Diagn Pathol 17:120–126.
  • Tischler AS (2008). Pheochromocytoma and extra-adrenal paraganglioma: Updates. Arch Pathol Lab Med 132:1272–1284.
  • Tischler AS, Coupland RE (1994). Changes in the structure and function of the adrenal medulla. In: Mohr U, Dungworth DL, Capen CC, eds. Pathobiology of the Aging Rat. Volume 2. Washington DC: ILSI Press, 245–268.
  • Tischler AS, Ruzicka LA, Donahue SR, DeLellis RA (1989). Chromaffin cell proliferation in the adult rat adrenal medulla. Int J Dev Neurosci 7:439–448.
  • Tischler AS, Riseberg JC, Cherington V (1994). Multiple mitogenic signalling pathways in chromaffin cells: a model for cell cycle regulation in the nervous system. Neurosci Lett 168:181–184.
  • Tischler AS, Powers JF, Downing JC, Riseberg JC, Shahsavari M, Ziar J, McClain RM (1996). Vitamin D3, lactose, and xylitol stimulate chromaffin cell proliferation in the rat adrenal medulla. Toxicol Appl Pharmacol 140:115–123.
  • Tischler AS, Powers JF, Pignatello M, Tsokas P, Downing JC, McClain RM (1999). Vitamin D3-induced proliferative lesions in the rat adrenal medulla. Toxicol Sci 51:9–18.
  • Tischler AS, Kimura N, McNicol AM (2006). Pathology of pheochromocytoma and extra-adrenal paraganglioma. Ann N Y Acad Sci 1073:557–570.
  • Tomlinson IP, Alam NA, Rowan AJ, Barclay E, Jaeger EE, Kelsell D, Leigh I, Gorman P, Lamlum H, Rahman S, Roylance RR, Olpin S, Bevan S, Barker K, Hearle N, Houlston RS, Kiuru M, Lehtonen R, Karhu A, Vilkki S, Laiho P, Eklund C, Vierimaa O, Aittomäki K, Hietala M, Sistonen P, Paetau A, Salovaara R, Herva R, Launonen V, Aaltonen LA; Multiple Leiomyoma Consortium (2002). Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet 30:406–410.
  • Toro JR, Nickerson ML, Wei MH, Warren MB, Glenn GM, Turner ML, Stewart L, Duray P, Tourre O, Sharma N, Choyke P, Stratton P, Merino M, Walther MM, Linehan WM, Schmidt LS, Zbar B (2003). Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. Am J Hum Genet 73:95–106.
  • TOXNET (2002). IRIS: Isoxaben. http://toxnetnlmnihgov/cgi-bin/sis/search
  • Tozaki-Saitoh H, Koizumi S, Sato Y, Tsuda M, Nagao T, Inoue K (2006). Retinoic acids increase P2X2 receptor expression through the 5’-flanking region of P2rx2 gene in rat phaeochromocytoma PC-12 cells. Mol Pharmacol 70:319–328.
  • Trenti T, Ventura E, Ceccarelli D, Masini A (1986a). Porphyrins and pentachlorophenol in rat-liver mitochondria in hexachlorobenzene-induced porphyria. IARC Sci Publ 77:457–459.
  • Trenti T, Ventura E, Ceccarelli D, Masini A (1986b). Functional derangement of liver mitochondria from hexachlorobenzene-treated rats. IARC Sci Publ 77:329–331.
  • Trovó-Marqui AB, Tajara EH (2006). Neurofibromin: A general outlook. Clin Genet 70:1–13.
  • Van Nederveen FH, Dinjens WN, Korpershoek E, De Krijger RR (2006). The occurrence of SDHB gene mutations in pheochromocytoma. Ann N Y Acad Sci 1073:177–182.
  • Watanabe H, Burnstock G, Jarrott B, Louis WJ (1976). Mitochondrial abnormalities in human phaeochromocytoma. Cell Tissue Res 172:281–288.
  • Weidemann A, Johnson RS (2008). Biology of HIF-1alpha. Cell Death Differ 15:621–627.
  • Wester PW, Krajnc EI, van Leeuwen FX, Loeber JG, van der Heijden CA, Vaessen HA, Helleman PW (1990). Chronic toxicity and carcinogenicity of bis(tri-n-butyltin) oxide (TBTO) in the rat. Food Chem Toxicol 28:179–196.
  • Woods JS, Carver GT, Fowler BA (1979). Altered regulation of hepatic heme metabolism by indium chloride. Toxicol Appl Pharmacol 49:455–461.
  • Young JB, Landsberg L (2001). Synthesis storage and secretion of adrenal medullary hormones: physiology and pathophysiology. In: McEwen BS, ed. Handbook of Physiology, Section 7: The Endocrine System, Volume IV: Coping with the Environment: Neural and Endocrine Mechanisms. New York: Oxford University Press, 3–19.
  • Yuan Y, Hilliard G, Ferguson T, Millhorn DE (2003). Cobalt inhibits the interaction between hypoxia-inducible factor-alpha and von Hippel-Lindau protein by direct binding to hypoxia-inducible factor-alpha. J Biol Chem 278:15911–15916.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.